M. Cronin

493 total citations
11 papers, 376 citations indexed

About

M. Cronin is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Neurology. According to data from OpenAlex, M. Cronin has authored 11 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Public Health, Environmental and Occupational Health, 4 papers in Epidemiology and 3 papers in Neurology. Recurrent topics in M. Cronin's work include Neuroendocrine Tumor Research Advances (4 papers), Reproductive Health and Contraception (4 papers) and Neuroblastoma Research and Treatments (3 papers). M. Cronin is often cited by papers focused on Neuroendocrine Tumor Research Advances (4 papers), Reproductive Health and Contraception (4 papers) and Neuroblastoma Research and Treatments (3 papers). M. Cronin collaborates with scholars based in United States and Germany. M. Cronin's co-authors include Eugene A. Woltering, Lowell Anthony, Kevin E. McCarthy, Gregory D. Espenan, B. Düsterberg, Christoph Gerlinger, W. Schmidt, Jan Endrikat, Christine Klipping and Thomas M. O’Dorisio and has published in prestigious journals such as Journal of Clinical Oncology, Contraception and Seminars in Nuclear Medicine.

In The Last Decade

M. Cronin

10 papers receiving 353 citations

Peers

M. Cronin

EPIDE

ONCOL

NEURO

RNMI

PHEOH

Francesca Nori Italy

Anna Zemczak Poland

Małgorzata Trofimiuk Poland

Kira Oleinikov Israel

Reynolds Jc United States

Helen C Miller United Kingdom

Małgorzata Trofimiuk–Müldner Poland

Anna Rizzello Italy

Agnieszka Kolasińska-Ćwikła Poland

J. Augui France

Francesca Nori Italy

M. Cronin

674 ×2.8

EPIDE

622 ×3.0

ONCOL

451 ×2.4

NEURO

60 ×0.7

RNMI

29 ×0.4

PHEOH

Citations per year, relative to M. Cronin M. Cronin (= 1×) peers Francesca Nori

Countries citing papers authored by M. Cronin

Since Specialization

Citations

This map shows the geographic impact of M. Cronin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Cronin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Cronin more than expected).

Fields of papers citing papers by M. Cronin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Cronin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Cronin. The network helps show where M. Cronin may publish in the future.

Co-authorship network of co-authors of M. Cronin

This figure shows the co-authorship network connecting the top 25 collaborators of M. Cronin. A scholar is included among the top collaborators of M. Cronin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Cronin. M. Cronin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Anthony, Lowell, M. Cronin, Thomas M. O’Dorisio, & M. Sue O’Dorisio. (2006). An open-label phase II study evaluating the safety and efficacy of PTK787 in patients with progressive metastatic neuroendocrine cancer. Journal of Clinical Oncology. 24(18_suppl). 14124–14124. 3 indexed citations

2.

Anthony, Lowell, et al.. (2004). Octreotide LAR doses used in clinical practice: Results from an internet survey and a clinical practice. Journal of Clinical Oncology. 22(14_suppl). 4274–4274. 11 indexed citations

3.

Anthony, Lowell, et al.. (2004). Octreotide LAR doses used in clinical practice: Results from an internet survey and a clinical practice. Journal of Clinical Oncology. 22(14_suppl). 4274–4274. 2 indexed citations

4.

Anthony, Lowell, et al.. (2002). Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies. Seminars in Nuclear Medicine. 32(2). 123–132. 202 indexed citations

5.

Klipping, Christine, et al.. (2002). An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables. Contraception. 65(3). 215–221. 44 indexed citations

6.

Endrikat, Jan, et al.. (2001). Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a 21-day regimen with 20 μg ethinyl estradiol and 150 μg desogestrel. Contraception. 64(3). 201–207. 27 indexed citations

7.

Endrikat, Jan, et al.. (2001). Double-blind, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day versus a 21-day low-dose oral contraceptive regimen containing 20 μg ethinyl estradiol and 75 μg gestodene. Contraception. 64(2). 99–105. 10 indexed citations

8.

Endrikat, Jan, et al.. (2001). Body weight change during use of a monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene with a comparison of the women who completed versus those who prematurely discontinued intake. The European Journal of Contraception & Reproductive Health Care. 6(4). 199–204. 5 indexed citations

9.

Endrikat, Jan, et al.. (2001). Blood pressure stability in a normotensive population during intake of a monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 g gestodene. The European Journal of Contraception & Reproductive Health Care. 6(3). 159–166.

10.

Lemen, Lisa, Gregory D. Espenan, Eugene A. Woltering, et al.. (1999). DOSE-ESCALATION OF INDIUM-111 PENTETREOTIDE (SOMATOTHER™): TOXICITY AND CLINICAL RESPONSE.. Clinical Nuclear Medicine. 24(3). 213–213. 2 indexed citations

11.

Cronin, M., et al.. (1998). In situ radiotherapy with 111In-pentetreotide: initial observations and future directions.. PubMed. 4(2). 94–102. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact